Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Issam Zineh

Showing results (41-50 of 127) with videos related to

Pageof 13
Sort By:
Metabolism: Clinical and Experimental|March 11, 2008
Relationship between plasma resistin concentrations, inflammatory chemokines, and components of the metabolic syndrome in adultsChristina L Aquilante, Lisa A Kosmiski, Shannon D Knutsen, et al.
Clinical Pharmacology and Therapeutics|October 2, 2018
Transporters in Drug Development: Scientific and Regulatory ConsiderationsLei Zhang, Shiew-Mei Huang, Kellie Reynolds, et al.
Clinical Pharmacology and Therapeutics|July 29, 2020
Regulatory Efforts to Facilitate Evaluation and Clinical Management of Drug-Drug Interaction RisksXinning Yang, Elimika Pfuma Fletcher, Shiew-Mei Huang, et al.
Journal of Pharmaceutical Sciences|May 29, 2013
The utility of modeling and simulation in drug development and regulatory reviewShiew-Mei Huang, Darrell R Abernethy, Yaning Wang, et al.
Journal of Clinical Pharmacology|July 25, 2025
Landscape of FDA-Approved Targeted Therapies for the Treatment of Diseases with Low Frequency Molecular SubsetsLois S Akinola, Sarah Ridge, Issam Zineh, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 29, 2023
US Food and Drug Administration embraces using innovation to identify optimized dosages for patients with cancerStacy S Shord, Hao Zhu, Jiang Liu, et al.
Journal of Clinical Pharmacology|February 2, 2023
US FDA Postmarketing Requirements and Commitments: A Systematic Assessment of Clinical Pharmacology Studies and Their Impact on US FDA Prescribing InformationSarah Ridge, Daphne Guinn, Elimika Pfuma Fletcher, et al.
Journal of Clinical Pharmacology|February 1, 2024
Statin Drug-Drug Interactions: Pharmacokinetic Basis of FDA Labeling Recommendations and Comparison Across Common Tertiary Clinical ResourcesJames Mease, Anuradha Ramamoorthy, Xinning Yang, et al.
Journal of Clinical Lipidology|August 4, 2009
Plasma Coenzyme Q10 Predicts Lipid-lowering Response to High-Dose AtorvastatinMichael A Pacanowski, Reginald F Frye, Osatohanmen Enogieru, et al.
Clinical Pharmacology and Therapeutics|October 6, 2020
A Systematic Assessment of US Food and Drug Administration Dosing Recommendations For Drug Development Programs Amenable to Response-Guided TitrationLingshan Wang, Kimberly Maxfield, Daphne Guinn, et al.
Pageof 13

Showing results (41-50 of 127) with videos related to

Sort By:
Pageof 13
Metabolism: Clinical and Experimental|March 11, 2008
Relationship between plasma resistin concentrations, inflammatory chemokines, and components of the metabolic syndrome in adultsChristina L Aquilante, Lisa A Kosmiski, Shannon D Knutsen, et al.
Clinical Pharmacology and Therapeutics|October 2, 2018
Transporters in Drug Development: Scientific and Regulatory ConsiderationsLei Zhang, Shiew-Mei Huang, Kellie Reynolds, et al.
Clinical Pharmacology and Therapeutics|July 29, 2020
Regulatory Efforts to Facilitate Evaluation and Clinical Management of Drug-Drug Interaction RisksXinning Yang, Elimika Pfuma Fletcher, Shiew-Mei Huang, et al.
Journal of Pharmaceutical Sciences|May 29, 2013
The utility of modeling and simulation in drug development and regulatory reviewShiew-Mei Huang, Darrell R Abernethy, Yaning Wang, et al.
Journal of Clinical Pharmacology|July 25, 2025
Landscape of FDA-Approved Targeted Therapies for the Treatment of Diseases with Low Frequency Molecular SubsetsLois S Akinola, Sarah Ridge, Issam Zineh, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 29, 2023
US Food and Drug Administration embraces using innovation to identify optimized dosages for patients with cancerStacy S Shord, Hao Zhu, Jiang Liu, et al.
Journal of Clinical Pharmacology|February 2, 2023
US FDA Postmarketing Requirements and Commitments: A Systematic Assessment of Clinical Pharmacology Studies and Their Impact on US FDA Prescribing InformationSarah Ridge, Daphne Guinn, Elimika Pfuma Fletcher, et al.
Journal of Clinical Pharmacology|February 1, 2024
Statin Drug-Drug Interactions: Pharmacokinetic Basis of FDA Labeling Recommendations and Comparison Across Common Tertiary Clinical ResourcesJames Mease, Anuradha Ramamoorthy, Xinning Yang, et al.
Journal of Clinical Lipidology|August 4, 2009
Plasma Coenzyme Q10 Predicts Lipid-lowering Response to High-Dose AtorvastatinMichael A Pacanowski, Reginald F Frye, Osatohanmen Enogieru, et al.
Clinical Pharmacology and Therapeutics|October 6, 2020
A Systematic Assessment of US Food and Drug Administration Dosing Recommendations For Drug Development Programs Amenable to Response-Guided TitrationLingshan Wang, Kimberly Maxfield, Daphne Guinn, et al.
Pageof 13